Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Issue of Supplementary Prospectus

22 Feb 2019 11:45



Issue of Supplementary Prospectus

Octopus AIM VCT plc

Octopus AIM VCT 2 plc

22 February 2019

Issue of Supplementary Prospectus

The Boards of Octopus AIM VCT plc and Octopus AIM VCT 2 plc (the “Companies") announce that a Supplementary Prospectus (the “Supplementary Prospectus") relating to the Offers for Subscription to raise up to £20 million, in aggregate, with an over-allotment facility of up to £10 million, in aggregate (the “Offers”), in the 2018/2019 and 2019/2020 tax years has been published today.

The Supplementary Prospectus refers to the publication of Octopus AIM VCT 2 plc's annual report and accounts for the year ended 30 November 2018 (the "2018 Accounts"), certain information from which is incorporated by reference into the Supplementary Prospectus.

A copy of the Supplementary Prospectus and the 2018 Accounts have been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:

http://www.morningstar.co.uk/uk/NSM

Copies of the Supplementary Prospectus will also be available from the Company's website:

http://www.octopusinvestments.com

For further enquiries, please contact:

Suzanna Waterhouse Company Secretary 020 3142 4957


Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.